129 related articles for article (PubMed ID: 26476591)
1. Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder.
Chang CC; Lee CT; Lan TH; Ju PC; Hsieh YH; Lai TJ
Psychiatry Res; 2015 Dec; 230(2):575-80. PubMed ID: 26476591
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.
Kotan VO; Sarandol E; Kirhan E; Ozkaya G; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1284-90. PubMed ID: 21515329
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
4. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.
Sarandol A; Sarandol E; Eker SS; Erdinc S; Vatansever E; Kirli S
Hum Psychopharmacol; 2007 Mar; 22(2):67-73. PubMed ID: 17299810
[TBL] [Abstract][Full Text] [Related]
5. Sertraline with desvenlafaxine and sertraline with mirtazapine as treatment initiation in MDD patients with moderate to severe depression and effect on inflammatory markers.
Arockiaraj N; Gupta R; Ahmad R; Halder S; Bhatia MS
Int J Psychiatry Clin Pract; 2024 Mar; 28(1):9-16. PubMed ID: 38019131
[TBL] [Abstract][Full Text] [Related]
6. Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients.
Jiang H; Chen S; Lu N; Yue Y; Yin Y; Zhang Y; Jiang W; Liang J; Yuan Y
World J Biol Psychiatry; 2017 Dec; 18(8):586-591. PubMed ID: 28635540
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis.
Jiménez-Fernández S; Gurpegui M; Díaz-Atienza F; Pérez-Costillas L; Gerstenberg M; Correll CU
J Clin Psychiatry; 2015 Dec; 76(12):1658-67. PubMed ID: 26579881
[TBL] [Abstract][Full Text] [Related]
8. Brain functional alterations observed 4-weekly in major depressive disorder following antidepressant treatment.
Yamagata B; Yamanaka K; Takei Y; Hotta S; Hirano J; Tabuchi H; Mimura M
J Affect Disord; 2019 Jun; 252():25-31. PubMed ID: 30959413
[TBL] [Abstract][Full Text] [Related]
9. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
10. Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study.
Ahmadpanah M; Ramezanshams F; Ghaleiha A; Akhondzadeh S; Sadeghi Bahmani D; Brand S
Psychiatry Res; 2019 Dec; 282():112613. PubMed ID: 31669837
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort.
Black CN; Bot M; Scheffer PG; Penninx BW
Psychol Med; 2017 Apr; 47(5):936-948. PubMed ID: 27928978
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, inflammation and treatment response in major depression.
Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
[TBL] [Abstract][Full Text] [Related]
13. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
14. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
[TBL] [Abstract][Full Text] [Related]
16. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated relationship of inflammation and oxidative stress in major depression.
Rawdin BJ; Mellon SH; Dhabhar FS; Epel ES; Puterman E; Su Y; Burke HM; Reus VI; Rosser R; Hamilton SP; Nelson JC; Wolkowitz OM
Brain Behav Immun; 2013 Jul; 31():143-52. PubMed ID: 23201587
[TBL] [Abstract][Full Text] [Related]
18. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive Brexpiprazole in Patients With Major Depressive Disorder and Irritability: An Exploratory Study.
Fava M; Ménard F; Davidsen CK; Baker RA
J Clin Psychiatry; 2016 Dec; 77(12):1695-1701. PubMed ID: 27379823
[TBL] [Abstract][Full Text] [Related]
20. Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder.
Zhang J; Yue Y; Thapa A; Fang J; Zhao S; Shi W; Yang Z; Li Y; Yuan Y
J Affect Disord; 2019 May; 250():432-438. PubMed ID: 30878656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
